
Description
for my product.
Possible product introduction:
CFI02 is a novel chemical compound with the CAS registry number of 273735-28-7, which belongs to the class of heterocyclic compounds containing two triazole rings linked by an imidazole linker. This compound has attracted growing attention from researchers and industrialists due to its potential applications as a building block, ligand, or inhibitor in various fields, such as medicinal chemistry, materials science, and organic synthesis.
As a manufacturer located in China, we have developed a reliable and cost-effective synthesis route for producing CFI02 in large scale and high purity. Our product has been tested by independent laboratories and confirmed to meet the standard specifications for this compound, including the appearance, melting point, elemental analysis, NMR spectrum, and HPLC purity. We also offer customized packaging and labeling options to fit the specific needs of our clients.
One of the main advantages of CFI02 is its versatility in functionalization and modification. By changing the substituents on the triazole or imidazole moieties, or by introducing additional functional groups, CFI02 can be tailored to exhibit different physicochemical properties and biological activities. For example, CFI02 derivatives have been reported to have potent antifungal, antibacterial, antitumor, and anticonvulsant activities. This makes CFI02 and its derivatives potential candidates for drug discovery and development.
Another application area of CFI02 is in the synthesis of complex organic molecules. CFI02 can be used as a key intermediate or building block for constructing diverse structures, such as triazole-linked peptoids and macrolides, imidazole-based chelators and metalloenzymes, and bioactive peptides and proteins. CFI02 can also serve as a ligand for coordinating with transition metals and generating new catalysts for organic reactions. Therefore, CFI02 has broad implications for chemical research and innovation.
Overall, CFI02 is a valuable chemical compound that offers multiple opportunities for research and development. By providing high-quality and affordable CFI02 products, we hope to assist our clients in their scientific pursuits and commercial activities. We welcome inquiries and orders from merchants in countries outside of China, and we are committed to providing excellent customer service and technical support. Thank you for considering our product.
Chemical Structure : CFI02
CAS No.: 273735-28-7

CFI02(CFI 02;CFI-02)
Catalog No.: URK-V2341 Only Used For Lab.
CFI02 (CFI-02) is a specific inhibitor of human cytomegalovirus (HCMV) glycoprotein B-mediated fusion with IC50 of 40 nM against laboratory adapted HCMV strain AD169.
Biological Activity
CFI02 (CFI-02) is a specific inhibitor of human cytomegalovirus (HCMV) glycoprotein B-mediated fusion with IC50 of 40 nM against laboratory adapted HCMV strain AD169; reduces HCMV yield by >3 logs at 1 uM, and shows no inhibitory activity against closely related betaherpesviruses (including MCMV, simian CMV, and RCMV) (IC50>20 uM) as well as cytotoxic effect (CC50>50 uM).
Physicochemical Properties
|
M.Wt |
491.43 |
|
|
Formula |
C18H11F6N5OS2 |
|
|
CAS No. |
273735-28-7 |
|
|
Storage |
Solide Powder -20 °C 3years; 4°C 2years |
In Solvent -80°C 6 Months -20°C 1 Months |
|
Solubility |
10 mM in DMSO |
|
|
Chemical Name |
N-(4-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)phenyl)-1,2,3-thiadiazole-4-carboxamide |
|
References
1. Jones TR, et al. J Virol. 2004 Feb;78(3):1289-300.
2. Bloom JD, et al. Bioorg Med Chem Lett. 2003 Sep 1;13(17):2929-32.
Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!
Why choose us?
- We are committed to providing environmentally friendly products.
- We hope that through our intentions and changes, we will continue to meet the individual needs of customers for CFI02 CAS No.:273735-28-7.
- Our products have been tested and verified by independent third-party agencies.
- We rely on our advantages in technology and management to attract advanced technology from abroad and transform the advantages into CFI02 CAS No.:273735-28-7 suitable for the market.
- Our products are manufactured with the utmost precision and care.
- We will strive to build ourselves into a high-quality enterprise of CFI02 CAS No.:273735-28-7 with the tenet of 'zero defect in quality and endless innovation'.
- Our products are manufactured to the highest standards of quality.
- We use training to identify and cultivate talents within the company and make optimal use of them, so that the company's success and personal growth are combined and there is a real interaction between the company and the employees.
- We are dedicated to building long-term relationships with our clients.
- We carefully choose suitable and qualified raw materials and firmly control the quality from the basis of products.
Hot Tags: cfi02 cas no.:273735-28-7, China cfi02 cas no.:273735-28-7, agonists for nuclear receptor activation, inhibitors for drug delivery, inhibitors for neurodegenerative diseases, inhibitors for growth factor signaling, agonists for cell proliferation, agonists for cardiovascular research
Send Inquiry
You Might Also Like







